Time to clinical improvement: an appropriate surrogate endpoint for pulmonary arterial hypertension medication trials.
Front Cardiovasc Med
; 10: 1142721, 2023.
Article
in En
| MEDLINE
| ID: mdl-37378404
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
/
Observational_studies
/
Risk_factors_studies
Language:
En
Journal:
Front Cardiovasc Med
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
Switzerland